GSS — Genetic Signatures Balance Sheet
0.000.00%
Last trade - 00:00- AU$93.13m
- AU$53.35m
- AU$14.27m
- 68
- 30
- 35
- 43
Annual balance sheet for Genetic Signatures, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 31.2 | 30.1 | 36.9 | 16.3 | 36.3 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 7.2 | 4.96 | 3.64 | 10.1 | 8.3 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 46.2 | 47.6 | 51.2 | 36.4 | 52.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3.51 | 6.05 | 6.78 | 7.22 | 8.49 |
| Net Intangible Assets | |||||
| Total Assets | 49.7 | 54 | 59.7 | 49.1 | 67.3 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.34 | 4.62 | 4.8 | 6.07 | 5.23 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.79 | 4.71 | 4.85 | 6.16 | 6.18 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 45.9 | 49.3 | 54.8 | 42.9 | 61.1 |
| Total Liabilities & Shareholders' Equity | 49.7 | 54 | 59.7 | 49.1 | 67.3 |
| Total Common Shares Outstanding |